Role of nitric oxide synthase type 2 in acute infection with murine cytomegalovirus

被引:52
作者
Noda, S [1 ]
Tanaka, K
Sawamura, S
Sasaki, M
Matsumoto, T
Mikami, K
Aiba, Y
Hasegawa, H
Kawabe, N
Koga, Y
机构
[1] Tokai Univ, Sch Med, Dept Infect Dis, Isehara, Kanagawa 2591193, Japan
[2] Tokai Univ, Sch Med, Cell Biol Res Lab, Isehara, Kanagawa 2591193, Japan
[3] Kyushu Univ, Med Inst Bioregulat, Fukuoka 812, Japan
关键词
D O I
10.4049/jimmunol.166.5.3533
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Whether or not NO plays a critical role in murine CMV (MCMV) infection has Set to be elucidated. In this study, we examined the role of NO in acute infection with MCMV using NO synthase type 2 (NOS2)-deficient mice. NOS2(-/-) mice were more susceptible to lethal infection with MCMV than NOS2(+/+) mice and generated a much higher peak virus titer in the salivary gland after acute infection. A moderate increase in the MCMV titer was also observed in other organs of NOS2(-/-) mice such as the spleen, lung, and liver. The immune responses to MCMV infection including NK cell cytotoxicity and CTL response in NOS2(-/-) mice were comparable with those of NOS2(+/+) mice. Moreover, the ability to produce IFN-gamma is not impaired in NOS2(-/-) mice after MCMV infection. The peritoneal macrophages from NOS2(-/-) mice, however, exhibited a lower antiviral activity than those from NOS2(+/+) mice, resulting in an enhanced viral replication in macrophages themselves, Treatment of these cells from NOS2(+/+) mice with a selective NOS2 inhibitor decreased the antiviral activity to a level below that obtained with NOS2(-/-) mice. In addition, the absence of NOS2 and NOS2-mediated antiviral activity of macrophages resulted in not only an enhanced MCMV replication and a high mortality but also a consequent risk of the latency. It was thus concluded that the NOS2-mediated antiviral activity of macrophages via NO plays a protective role against MCMV infection at an early and late stage of the infection.
引用
收藏
页码:3533 / 3541
页数:9
相关论文
共 61 条
  • [1] Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function
    Adachi, O
    Kawai, T
    Takeda, K
    Matsumoto, M
    Tsutsui, H
    Sakagami, M
    Nakanishi, K
    Akira, S
    [J]. IMMUNITY, 1998, 9 (01) : 143 - 150
  • [2] Akaike T, 1998, P SOC EXP BIOL MED, V217, P64
  • [3] Inducible nitric-oxide synthase plays a minimal role in lymphocytic choriomeningitis virus-induced, T cell-mediated protective immunity and immunopathology
    Bartholdy, C
    Nansen, A
    Christensen, JE
    Marker, O
    Thomsen, AR
    [J]. JOURNAL OF GENERAL VIROLOGY, 1999, 80 : 2997 - 3005
  • [4] INHIBITION OF VESICULAR STOMATITIS-VIRUS INFECTION BY NITRIC-OXIDE
    BI, ZB
    REISS, CS
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (04) : 2208 - 2213
  • [5] DENSITY-DEPENDENT INHIBITION OF MOUSE EMBRYO FIBROBLAST GROWTH - INVOLVEMENT OF IGFBP-3
    BLAT, C
    VILLAUDY, J
    HAREL, L
    [J]. EXPERIMENTAL CELL RESEARCH, 1994, 215 (01) : 114 - 118
  • [6] Bodaghi B, 1999, J IMMUNOL, V162, P957
  • [7] PATHOGENESIS OF MURINE CYTOMEGALOVIRUS-INFECTION IN NATURAL-KILLER CELL-DEPLETED MICE
    BUKOWSKI, JF
    WODA, BA
    WELSH, RM
    [J]. JOURNAL OF VIROLOGY, 1984, 52 (01) : 119 - 128
  • [8] Requirement for type 2 NO synthase for IL-12 signaling in innate immunity
    Diefenbach, A
    Schindler, H
    Röllinghoff, M
    Yokoyama, WM
    Bogdan, C
    [J]. SCIENCE, 1999, 284 (5416) : 951 - 955
  • [9] Type 1 interferon (IFNα/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite
    Diefenbach, A
    Schindler, H
    Donhauser, N
    Lorenz, E
    Laskay, T
    MacMicking, J
    Röllinghoff, M
    Gresser, I
    Bogdan, C
    [J]. IMMUNITY, 1998, 8 (01) : 77 - 87
  • [10] DING AH, 1988, J IMMUNOL, V141, P2407